1 / 27

Drug Use in the Elderly

valiant
Download Presentation

Drug Use in the Elderly

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. It is much easier to write upon a disease than upon a remedy. The former is in the hands of nature and a faithful observer with an eye of tolerable judgement cannot fail to delineate a likeness. The latter will ever be subject to the whim, the inaccuracies and the blunder of mankind. William Withering (1741-1799)

  2. A desire to take medicine is, perhaps, the great feature which distinguishes man from other animals.Sir William Osler, 1891

  3. “I know of no way to end an office visit as satisfactorily and as efficiently as by writing a prescription. The patient knows that the visit is over and is expected to leave. He has something in his hand that he thinks will help him and obtaining it required an office visit.” Marcus Reidenberg, MD Editor Emeritus, CP&T

  4. Drug Use in the Elderly • 57% of all elderly use > 5 drugs per week • 19% of elderly use > 10 drugs per week Slone Survey, 2006

  5. Suboptimal Medication Use • Overuse • Inappropriate prescribing • Underuse Hanlon JT et al. JAGS. 2001;49: 200-9. Fisk D et al. Arch Intern Med. 2003;163: 2716-2724.

  6. Polypharmacy Polypharmacy is not necessarily bad!

  7. Drug Regimen Changes ~They are very common! • Any transition - hospitalizations, discharges, ER visits, subacute care stays • New meds, different doses… • Changes from generic to brand- nomenclature, color and/or shape

  8. Why so many changes? • The more providers and visits, the more medications are prescribed • 2/3 of all physician visits end with a prescription • Expectations of the patient to receive a prescription • Lack of communication between prescribers • Self-treatment: unbeknownst to the physician

  9. Impact on the Patient • Increased risk of adverse drug events and near-misses • Noncompliance or nonadherence leading to poor outcomes • Increased costs

  10. Factors Influencing Drug Effects and Risk of Adverse Effects in the Elderly • Multiple co-existing illnesses • Polypharmacy: redundant effects and drug-drug interactions • Adverse drug effects nonspecific • Pharmacologic changes with aging • Medical error

  11. Pharmacokinetics: Changes with Aging • Absorption • Distribution • Metabolism • Excretion

  12. Body Composition Changes in Adult Men with Aging Data adapted from Cohn et al, 1980

  13. Hepatic Metabolism of DrugsChanges with Aging • Phase I reactions- primarily oxidative reactions • Decline in efficiency with aging • Phase II reactions- conjugation reactions • No decline in efficiency with aging

  14. Renal Function: Changes with Aging Creatinine Clearance Age

  15. t1/2 ~ Vd/Clearance

  16. Pharmacodynamics: Changes with Aging

  17. Clinical Pearl Any new symptom in an elderly patient should be considered a drug side effect until proven otherwise. Jerry Avorn, MD

  18. The Prescribing Cascade Drug 1 ADE Drug 2

  19. The Prescribing Cascade Metoclopramide Extrapyramidal Effects Levodopa Rx

  20. Case-Control Study Design CLASSIFY/COMPARE BEGIN Metoclopramide: Yes or No? L-dopa Rx Metoclopramide: Yes or No? Controls

  21. Results Metoclopramide users were over three times more likely to begin use of L-dopa therapy compared with non-users (OR=3.09; 95% CI 2.25 to 4.26).

  22. Likelihood of L-dopa Treatment by Metoclopramide Dose

  23. Conclusion Metoclopramide confers an increased risk for the initiation of treatment generally reserved for the managment of idiopathic Parkinson’s disease. Avorn et al, JAMA, 1995

  24. Improving the Quality of Prescribing to Older Adults • Medication reconciliation – at time of transitions • Anticipate errors – prescribing & monitoring • Watch out for prescribing cascades • Simplify the medication regimen • Identify obstacles (costs, cognitive impairment) • Enlist family/nursing/PCP support & involvement • Make sure there is good follow-up

  25. Lessons from the Case

More Related